These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28165585)

  • 81. Efficacy and safety of direct-acting antiviral-based treatment in hepatitis C virus infected patients with chronic renal function impairment: An updated systemic review and meta-analysis.
    Yang H; Hu X; Pu L; Ren S; Feng Y
    Nephrology (Carlton); 2020 Nov; 25(11):829-838. PubMed ID: 32108975
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
    Crippin JS; McCashland T; Terrault N; Sheiner P; Charlton MR
    Liver Transpl; 2002 Apr; 8(4):350-5. PubMed ID: 11965579
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
    Landau DA; Scerra S; Sene D; Resche-Rigon M; Saadoun D; Cacoub P
    J Rheumatol; 2010 Mar; 37(3):615-21. PubMed ID: 20110523
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.
    Schulte B; Schütt S; Brack J; Isernhagen K; Deibler P; Dilg C; Verthein U; Haasen C; Reimer J
    Drug Alcohol Depend; 2010 Jun; 109(1-3):248-51. PubMed ID: 20167441
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population.
    Teegen EM; Globke B; Schott E; Pratschke J; Eurich D
    Exp Clin Transplant; 2018 Feb; 16(1):61-67. PubMed ID: 29137590
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Caution with the use of the new direct acting antivirals in the hepatitis C virus related renal disease.
    Gomis A; Díaz M; de Lorenzo A; Ruiz-Roso G; Liaño F
    Nefrologia; 2016; 36(6):713-715. PubMed ID: 27575928
    [No Abstract]   [Full Text] [Related]  

  • 87. Recommendations for the treatment of hepatitis C virus infection in chronic kidney disease: a position statement by the Spanish association of the liver and the kidney.
    Aoufi-Rabih S; García-Agudo R; Londoño MC; Fraga-Fuentes MD; Barril-Cuadrado G;
    J Nephrol; 2018 Feb; 31(1):1-13. PubMed ID: 29064081
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease.
    Gordon CE; Balk EM; Francis JM
    Semin Dial; 2019 Mar; 32(2):187-195. PubMed ID: 30496617
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.
    Martin P; Awan AA; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Jadoul M
    Kidney Int; 2022 Dec; 102(6):1228-1237. PubMed ID: 36411019
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Eradicating the Viral Triad in Hemodialysis Units.
    Adams B; Yee J
    Adv Chronic Kidney Dis; 2019 May; 26(3):157-161. PubMed ID: 31202386
    [No Abstract]   [Full Text] [Related]  

  • 91. Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study.
    Basso M; Zago D; Pozzetto I; Parisi SG
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1076-e1077. PubMed ID: 35048665
    [No Abstract]   [Full Text] [Related]  

  • 92. Approach to a patient with hepatitis c: diagnosis and pretreatment assessment.
    Ołdakowska-Jedynak U; Malyszko J
    Wiad Lek; 2019; 72(11 cz 2):2218-2221. PubMed ID: 31860840
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Role of Genedrive in Point of Care Method For Hepatitis C Elimination in Hemodialysis Center.
    Sulaiman AS; Indrasari ND; Hustrini NM; Rachmani D
    Acta Med Indones; 2024 Apr; 56(2):185-190. PubMed ID: 39010767
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hepatitis C Care Pathway Associated With Increased Screening, Confirmation, and Diagnosis Communication to Patients.
    Rodriguez-Watson C; Rubenstein KB; Jonas MC; Sun Y; Horberg M; Loftus B
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):607-609.e2. PubMed ID: 31927112
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Viral Load Measurements in Individuals with Hepatitis C Virus Infection: on the European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C 2018.
    Rando-Segura A; Buti M; Quer J; López-Martínez R; Rodríguez-Frías F
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666360
    [No Abstract]   [Full Text] [Related]  

  • 96. Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials.
    Harrington PR; Deming DJ; Komatsu TE; Naeger LK
    Clin Infect Dis; 2015 Aug; 61(4):666-7. PubMed ID: 26002846
    [No Abstract]   [Full Text] [Related]  

  • 97. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
    Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
    Infection; 2019 Feb; 47(1):141-168. PubMed ID: 30255389
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].
    Rao HY; Duan ZP; Wang GQ; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Update to hepatitis C review.
    Fabrizi F; Messa P; Martin P
    Kidney Int; 2014 May; 85(5):1238-9. PubMed ID: 24786879
    [No Abstract]   [Full Text] [Related]  

  • 100. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
    AASLD-IDSA HCV Guidance Panel
    Clin Infect Dis; 2018 Oct; 67(10):1477-1492. PubMed ID: 30215672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.